U.S. Hospitality Stock News

OSI Systems reported strong first quarter results for the period ended September 30, 2025, with revenue rising to US$384.62 million and net income reaching US$20.56 million, alongside an increase in both basic and diluted earnings per share compared to the previous year. The company also raised its full-year revenue guidance for Fiscal Year 2026, underscoring confidence in continued growth from recurring service revenue and new government contract awards across core sectors. We will explore...

Rivian Automotive recently reported third-quarter results, with revenue rising to US$1.56 billion and the company achieving its first-ever positive gross profit, while maintaining its 2025 delivery guidance of 41,500 to 43,500 vehicles. An interesting development is Rivian's continued progress on launching its more affordable R2 SUV, expected to drive broader consumer interest and future revenue opportunities. We'll now explore how Rivian's move to positive gross profit signals a shift in...

EverCommerce Inc. recently reported third quarter 2025 earnings, highlighting a rise in revenue to US$147.47 million and a swing to net income of US$11.12 million from a loss in the prior year, while also providing updated revenue guidance for the fourth quarter and full year 2025. Recent developments, including the acquisition of ZyraTalk and divestiture of its marketing technology segment, underscore EverCommerce’s sharper focus on accelerating AI integration and expanding its core SaaS...

Hexcel (HXL) has delivered steady returns over the past year, with shares rising about 13%. Investors might be wondering what factors could be at play as the stock continues its upward trend this month. See our latest analysis for Hexcel. Hexcel’s momentum has picked up lately, with a notable 11.4% share price return over the past month and a solid one-year total shareholder return of 13.3%. This gain adds to a longer-term track record of steady performance, suggesting growing investor...

APi Group Corporation recently reported third-quarter 2025 results, showing sales of US$2,085 million and net income of US$93 million, while also raising its full-year net revenue guidance to US$7.83–7.93 billion. Despite the improved outlook and strong financials, a major insider, 10% shareholder Franklin Martin E., sold 900,000 shares earlier in November, drawing attention to recent insider activity around these announcements. With management raising its full-year revenue forecast after...

Broadcom (AVGO) just landed major custom AI chip orders from heavyweights like Google, Meta, Anthropic, and OpenAI, pushing its revenue backlog past $100 billion. These developments have investors and analysts taking a keen interest as the company’s next earnings report approaches. See our latest analysis for Broadcom. Broadcom’s stock has seen some dramatic swings lately, with a recent pullback tracing back to caution around high valuations and a broader market cooldown. Even so, the...

Corcept Therapeutics (CORT) posted its third-quarter results, highlighting revenue growth fueled by new Korlym prescriptions. However, revenue and net income were lower than forecasts. The company has revised its 2025 revenue guidance. See our latest analysis for Corcept Therapeutics. Corcept Therapeutics’ latest earnings call set the stage for a year marked by both operational pivots and anticipation, with FDA decisions ahead and strategic efforts to ease specialty pharmacy bottlenecks...

Amneal Pharmaceuticals (AMRX) just posted higher sales and swung to a profit for the third quarter, while rolling out two product milestones in respiratory and migraine care that could shape its next phase. See our latest analysis for Amneal Pharmaceuticals. After a stretch of business execution and key product launches, Amneal’s 30-day share price return of 14% and year-to-date gain of 46.5% have outpaced the S&P 500. Its three-year total shareholder return of 362% underscores an impressive...

Apogee Therapeutics (APGE) just completed a public offering, bringing in about $345 million in fresh capital. The timing comes as several analysts begin coverage and highlight confidence in Apogee’s drug pipeline and leadership. See our latest analysis for Apogee Therapeutics. After raising fresh funding and earning positive analyst attention, Apogee Therapeutics has seen momentum build in its share price, with a rise of 58% over the past 90 days. However, the total shareholder return over...

Semrush Holdings (SEMR) shares have caught some attention lately, as investors dip in to assess its performance following a modest recovery over the past month. The stock’s recent moves come as its year-to-date return remains deeply negative. See our latest analysis for Semrush Holdings. Semrush Holdings’ share price has bounced back slightly in the past month, but momentum remains hard to find given its year-to-date decline of 38.3% and a steep 45.4% total shareholder loss over the last...

Quaker Chemical (KWR) has seen shares move steadily in recent weeks, with the stock up 10% over the past month. Investors may be watching for underlying trends in demand or upcoming catalysts that could impact valuation. See our latest analysis for Quaker Chemical. Momentum has returned for Quaker Chemical. After a 1-month share price return of nearly 10%, the stock is recovering some ground even as its 1-year total shareholder return remains notably negative. Investors seem to be...

Curious if Ardagh Metal Packaging’s stock is a hidden gem or just another name in the packaging space? Let’s dive into the numbers behind the share price to help you work out if it’s a smart buy today. Even though the shares are up 14.5% so far this year, they have lost 4.8% in the last week and over 6% in the past month. This suggests a mix of strong longer-term momentum and some recent investor caution. A recent uptick in industry demand and Ardagh Metal Packaging’s strategic push into...

UDR (UDR) has seen its stock drift slightly over the past month, with a small gain for the week but a decline when looking at the past three months. Investors may be weighing longer-term performance trends. See our latest analysis for UDR. UDR’s share price has taken a hit this year, falling nearly 19% year-to-date, and its total shareholder return is also down over the past twelve months. This signals that momentum has been on the softer side, despite some recent rebounds. Investors seem to...

TechnipFMC (FTI) has posted a solid stretch recently, delivering a year-to-date return near 45% and climbing almost 23% over the past 3 months. Many investors are taking a closer look at what has fueled this momentum. See our latest analysis for TechnipFMC. Momentum for TechnipFMC has really picked up, with a nearly 45% year-to-date share price return and recent total shareholder returns showing multi-year strength. The latest price surge suggests renewed investor optimism around the...

Aon (AON) just reported its third-quarter results, and the numbers came in stronger than many expected. Revenue growth was particularly healthy, and management’s outlook for 2025 remains upbeat with a focus on cashflow. See our latest analysis for Aon. Aon’s momentum remains a talking point this year, as better-than-expected results and disciplined capital management have caught investors’ attention. While the share price is down around 2% for 2025 so far, recent strength, including a 1.9%...

Science Applications International (SAIC) has seen its stock performance draw attention recently, especially as investors consider how the company's current valuation compares with its results over the past year. Recent returns reveal a notable divergence from broader market trends. See our latest analysis for Science Applications International. Although Science Applications International's share price has dipped in recent months, including a 20.76% decline over the past 90 days, this follows...

Summit Therapeutics (SMMT) revealed new data from its HARMONi-A Phase III trial, showing that ivonescimab plus chemotherapy led to improved overall survival in patients with EGFR-mutated non-small cell lung cancer. This milestone highlights the potential impact of ivonescimab for patients and the company’s ongoing development strategy. See our latest analysis for Summit Therapeutics. Summit’s breakthrough in the HARMONi-A trial comes after a turbulent year on the market. The company’s 1-year...

Credit Acceptance (CACC) just released its third quarter results, revealing higher revenue and net income compared to last year. The announcement also came with news of an upcoming change in company leadership. See our latest analysis for Credit Acceptance. After a solid stretch of buybacks and new leadership news, Credit Acceptance’s momentum has cooled with a 30-day share price return of -11.77%. Still, despite some recent pressure, its five-year total shareholder return stands at an...

TETRA Technologies (TTI) posted third quarter earnings that showed solid progress, with both revenue and net income up compared to last year. Investors are watching this performance because it highlights continued profit growth in recent months. See our latest analysis for TETRA Technologies. TETRA Technologies’ robust third-quarter earnings update appears to have sparked real momentum, with the company’s share price climbing 35.2% over the past month and more than doubling year-to-date...

Wintrust Financial (WTFC) has continued to pique investor interest as its stock posts a month return of 4% and is up 7% over the past 3 months. As questions about the bank sector’s momentum persist, it is worth looking at what is behind these numbers. See our latest analysis for Wintrust Financial. The share price of Wintrust Financial sits at $130.62, reflecting solid momentum in recent weeks and adding to its reputation for steady growth. While banking stocks have had their ups and downs,...

AMC Entertainment Holdings (AMC) has been grabbing attention as investors continue to monitor its share price, which recently declined while broader markets traded sideways. With the company’s stock falling sharply over the past month, market participants are watching closely to see if this trend continues or if a rebound is in sight. See our latest analysis for AMC Entertainment Holdings. AMC’s share price has been under continued pressure, most recently sliding 18.3% over the past month and...

Artisan Partners Asset Management (APAM) released its third quarter results. The company reported higher revenue than last year, but net income and earnings per share declined. Artisan Partners also declared a variable quarterly dividend tied to its cash generation. See our latest analysis for Artisan Partners Asset Management. After a variable dividend announcement and new earnings numbers, Artisan Partners Asset Management’s share price has climbed 5.94% over the past month and now trades...

Mind Medicine (MindMed) recently reported third-quarter results showing a net loss of US$67.27 million, a sizeable increase from US$13.68 million a year ago, alongside a follow-on equity offering raising approximately US$225 million to support research, development, and potential acquisitions. The pronounced rise in reported losses highlights ongoing investment in MindMed’s pipeline, with the newly raised capital intended to fund future growth and operational needs. With losses widening...

Two Harbors Investment (TWO) is back in the spotlight after filing a shelf registration for over $7 million in common stock, along with its latest quarterly earnings release. Both developments have investors weighing future scenarios. See our latest analysis for Two Harbors Investment. After announcing a new shelf registration for common stock and revealing extended net losses in its quarterly report, Two Harbors Investment’s share price remains under pressure. The 1-year total shareholder...